Patients who survive life-threatening ventricular arrhythmias are at risk
for recurrent arrhythmias and can be treated with either an implantable
cardio-verter-defibrillator or antiarrhythmic drugs. In last week's New
England Journal of Medicine, a research study chaired by IUSM cardiologist
Douglas P. Zipes, reported that among survivors of ven-tricular
fibrillation or sustained ventricular tachycardia causing severe
symptoms, the implantable cardioverter-defibrillator is superior to
antiarrhythmic drugs for increasing overall survival.
Mark your new year calendar: The Martin Luther King Dinner, sponsored by
the Black Student Union at IUPUI, will be Jan. 19. Benjamin L. Hooks,
former executive director of the NAACP, will keynote the 28th annual
event. Call 317-274-3931 for ticket information.
For more on line: 
Return to Table of Contents